NEO Competitors & Alternatives
Compare NeoGenomics Inc with similar stocks in the same industry
Diagnostics & Research
NEO
Main Stock$18.47
Tradestie Score
28
Market Cap
$1.13B
Revenue Growth
0.1%
Analyst Upside
+6.8%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$73.09
|
$3.26B | - | 60 | Compare |
|
VCYT
Veracyte, Inc.
|
$45.81
|
$2.85B | 33.0 | 38 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$143.26
|
$2.24B | - | 32 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$28.35
|
$2.22B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$188.67
|
$1.77B | - | 32 | Compare |
|
NVCR
NovoCure Limited Ordinary Shares
|
$14.94
|
$1.56B | - | 50 | Compare |
|
NEOG
Neogen Corp
|
$12.15
|
$1.26B | - | 42 | Compare |
|
OPK
Opko Health Inc.
|
$1.56
|
$1.23B | - | 41 | Compare |
|
CDNA
CareDx, Inc.
|
$67.15
|
$798.40M | 31.8 | 29 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$21.48
|
$719.31M | - | 46 | Compare |
More NEO Analysis
Data updated: Oct 03, 2026 | Industry: Diagnostics & Research (SIC 8734)
35 stocks in this industry